يعرض 1 - 20 نتائج من 93 نتيجة بحث عن '"Jan, Pødenphant"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
  4. 4

    المصدر: Herly, M, Stengaard-Pedersen, K, Hørslev-Petersen, K, Hetland, M L, Østergaard, M, Christensen, R, Løgstrup, B B, Vestergaard, P, Pødenphant, J, Junker, P & Ellingsen, T 2017, ' Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial : protocol for a cohort study with patient-record evaluated outcomes ', BMJ Open, vol. 7, no. 4, e014816 . https://doi.org/10.1136/bmjopen-2016-014816
    Herly, M, Stengaard-Pedersen, K, Horslev-Petersen, K, Hetland, M L, Østergaard, M, Christensen, R, Løgstrup, B B, Vestergaard, P, Pødenphant, J, Junker, P & Ellingsen, T 2017, ' Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes ' BMJ Open . https://doi.org/10.1136/bmjopen-2016-014816
    BMJ Open
    Herly, M, Stengaard-Pedersen, K, Hørslev-Petersen, K, Hetland, M L, Østergaard, M, Christensen, R, Løgstrup, B B, Vestergaard, P, Pødenphant, J, Junker, P & Ellingsen, T 2017, ' Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial : protocol for a cohort study with patient-record evaluated outcomes ', B M J Open, vol. 7, e014816 . https://doi.org/10.1136/bmjopen-2016-014816

    وصف الملف: application/pdf

  5. 5

    المصدر: Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA study group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : Results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
    Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, M P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Østergaard, M & OPERA Study Group 2014, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2013-204537
    Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J R, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I T, Horn, H C, Ammitzbøll, C G, Jørgensen, A J, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA Study Group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537

  6. 6

    المصدر: Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Ostergaard, M, Stengaard-Pedersen, K & OPERA study-group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : An investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
    Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Tønder Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2013, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2012-202735
    OPERA Study Group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life : The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735

  7. 7
  8. 8
  9. 9

    المصدر: Jacobsen, S, Garred, P, Madsen, H O, Heegaard, N H H, Hetland, M L, Stengaard-Pedersen, K, Junker, P, Lottenburger, T, Ellingsen, T, Smedegaard Andersen, L, Hansen, I, Skjødt, H, Pedersen, J K, Lauridsen, U B, Svendsen, A J, Tarp, U, Pødenphant, J, Lindegaard, H, Vestergaard, A, Østergaard, M & Hørslev-Petersen, K 2009, ' Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis ', Journal of Rheumatology, vol. 36, no. 4, pp. 731-5 . https://doi.org/10.3899/jrheum.080846

  10. 10

    المصدر: Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, D & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550
    Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Hetland, M L, Jurik, A G, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Junker, P, Krogh, N S, Lottenburger, T, Ellingsen, T, Andersen, L S, Skjødt, H, Svendsen, A J, Tarp, U, Hansen, I T, Pødenphant, J, Pedersen, J K, Lindegaard, H, Hanson, L G, Vestergaard, A, Glinatsi, M & Østergaard, M 2017, ' Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis : results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA) ', Scandinavian Journal of Rheumatology, vol. 46, no. 5, pp. 335-345 . https://doi.org/10.1080/03009742.2016.1209550

  11. 11

    المصدر: Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study-Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
    Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
    Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166

  12. 12

    المصدر: Hjardem, E, Østergaard, M, Pødenphant, J, Tarp, U, Andersen, L S, Bing, J, Peen, E, Lindegaard, H M, Ringsdal, V S, Rødgaard, A, Skøt, J, Hansen, A, Mogensen, H H, Unkerskov, J & Hetland, M L 2007, ' Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor? ', Annals of the Rheumatic Diseases, vol. 66, no. 9, pp. 1184-1189 .
    University of Southern Denmark
    Hjardem, E, Østergaard, M, Pødenphant, J, Tarp, U, Andersen, L S, Bing, J, Peen, E, Lindegaard, H M, Ringsdal, V S, Rødgaard, A, Skøt, J, Hansen, A, Mogensen, H H, Unkerskov, J & Hetland, M L 2007, ' Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor? ', Annals of the Rheumatic Diseases, vol. 66, no. 9, pp. 1184-9 . https://doi.org/10.1136/ard.2006.054742

  13. 13

    المصدر: Møller-Bisgaard, S, Ejbjerg, B J, Eshed, I, Hørslev-Petersen, K, Jurik, A G, Vallø, J, Thomsen, H, Torfing, T, Stengaard-Pedersen, K, Hetland, M L, Junker, P, Steen Krogh, N, Lottenburger, T, Ellingsen, T, Smedegaard-Andersen, L, Hansen, I, Skjødt, H, Svendsen, A J, Tarp, U, Pødenphant, J, Lindegaard, H M & Østergaard, M 2015, ' Effect of Methotrexate and Intra-Articular Betamethasone with or Without Additional Cyclosporine on Magnetic Resonance Imaging (MRI)-Determined Inflammatory and Destructive Changes in Very Early Rheumatoid Arthritis – Results from a 24-Months' Randomised Double Blind Placebo Controlled Trial ', 16th Annual European Congress of Rheumatology, Rom, Italy, 10/06/2015-13/06/2015 . < http://dx.doi.org/10.1136/annrheumdis-2015-eular.2808 >
    University of Southern Denmark

  14. 14
  15. 15

    المصدر: Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Nielsen, K R, Ellingsen, T, Hetland, M L, Junker, P, Pødenphant, J, Østergaard, M, Johansen, J, Hørslev-Petersen, K & Stengaard-Pedersen, K 2015, ' Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis ', Arthritis & rheumatology (Hoboken, N.J.), vol. 67, no. suppl 10, 2589 . https://doi.org/10.1002/art.39448
    Ammitzbøll, C G, Steffensen, R N, Bøgsted, M, Nielsen, K R, Ellingsen, T, Hetland, M L, Junker, P, Pødenphant, J, Østergaard, M, Johansen, J, Hørslev-Petersen, K & Stengaard-Pedersen, K 2015, ' Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis ', ACR/ARHP, San Francisco, United States, 07/11/2015-11/11/2015 .
    Publons
    University of Southern Denmark
    Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Nielsen, K R, Ellingsen, T, Hetland, M L, Junker, P, Pødenphandt, J, Østergaard, M, Johansen, J, Hørslev-Petersen, K & Stengaard-Pedersen, K 2015, ' Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis ', ACR/ARHP, San Francisco, United States, 07/11/2015-11/11/2015 .

  16. 16

    المصدر: Krol, A, Garred, P, Heegaard, NHH, Christensen, A F, Hetland, ML, Stengaard-Pedersen, K, Junker, P, Madsen, H, Lottenburger, T, Ellingsen, T, Andersen, L, Hansen, I, Pedersen, J, Svendsen, A J, Tarp, U, Pødenphant, J, Lindegaard, H, Østergaard, M, Hørslev-Petersen, K & Jacobsen, S 2015, ' Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis ', Scandinavian Journal of Rheumatology, vol. 44, no. 1, pp. 8-12 . https://doi.org/10.3109/03009742.2014.918651
    Krol, A, Garred, P, Heegaard, N, Christensen, AF, Hetland, M, Stengaard-Pedersen, K, Junker, P, Madsen, HO, Lottenburger, T, Ellingsen, T, Andersen, LS, Hansen, I, Pedersen, JK, Svendsen, AJ, Tarp, U, Pødenphant, J, Lindegaard, H, Østergaard, M, Hørslev-Petersen, K & Jacobsen, S 2015, ' Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis ', Scandinavian Journal of Rheumatology, vol. 44, no. 1, pp. 8-12 . https://doi.org/10.3109/03009742.2014.918651

  17. 17

    المصدر: Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', Pharmacogenomics Journal, vol. 16, no. 2, pp. 141-146 . https://doi.org/10.1038/tpj.2015.30
    Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', Pharmacogenomics Journal, vol. 16, no. 2, pp. 141-6 . https://doi.org/10.1038/tpj.2015.30
    Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Østergaard, M, Stengaard-Pedersen, K & Johansen, J S 2016, ' Prediction of treatment response to adalimumab : a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis ', The Pharmacogenomics Journal, vol. 16, no. 2, pp. 141–146 . https://doi.org/10.1038/tpj.2015.30

  18. 18
  19. 19
  20. 20

    المصدر: Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Østergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, ' CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients ', Arthritis Research & Therapy
    , vol. 16, no. 5, 475, pp. 1-8 . https://doi.org/10.1186/s13075-014-0475-3
    Ammitzbøll, C, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Ostergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, ' CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients ', Arthritis Research & Therapy, vol. 16, no. 5, 475 . https://doi.org/10.1186/s13075-014-0475-3
    Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Østergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, ' CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients ', Arthritis research & therapy, vol. 16, no. 5, pp. 475 . https://doi.org/10.1186/s13075-014-0475-3
    Ammitzbøll, C, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Ostergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, ' CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients ', Arthritis Research & Therapy, vol. 16, no. 1, 475 . https://doi.org/10.1186/s13075-014-0475-3
    Arthritis Research & Therapy

    وصف الملف: application/pdf